SCHEMBL7836834

SCHEMBL7836834

O=C1NC(=O)C(Cc2ccc(OCc3nc4ncccc4[nH]3)cc2)S1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 13/20 0.56
PPARA Q07869 6/20 0.56
PPARG P37231 9/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7838282 0.81 PPARG (0.48) FFAR1PPARAPPARG
SCHEMBL877848 0.78 PPARG (0.65) FFAR1PPARAPPARG
SCHEMBL3370792 0.78 PPARG (0.62) FFAR1PPARAPPARG
SCHEMBL4622433 0.77 PPARG (0.57) FFAR1PPARAPPARG
SCHEMBL7838277 0.77 PPARG (0.67) FFAR1PPARAPPARG
Hydrochloric Acid SCHEMBL501421 0.77 PPARG (0.61) FFAR1PPARAPPARG
SCHEMBL8312136 0.77 FFAR1 (0.87) FFAR1PPARAPPARG
SCHEMBL9803889 0.76 PPARG (0.64) FFAR1PPARAPPARG
SCHEMBL1299855 0.75 FFAR1 (0.80) FFAR1PPARAPPARG
SCHEMBL8314978 0.75 FFAR1 (0.70) FFAR1PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed